SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of : (a) Silverback Therapeutics Inc. (NASDAQ: SBTX) common stock pursuant and/or traceable to the offering documents issued in connection with Silverback…
